DK167218B1 - Aminoacyllabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af laegemidler - Google Patents

Aminoacyllabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af laegemidler Download PDF

Info

Publication number
DK167218B1
DK167218B1 DK578585A DK578585A DK167218B1 DK 167218 B1 DK167218 B1 DK 167218B1 DK 578585 A DK578585 A DK 578585A DK 578585 A DK578585 A DK 578585A DK 167218 B1 DK167218 B1 DK 167218B1
Authority
DK
Denmark
Prior art keywords
formula
oil
solution
ethyl acetate
lower alkyl
Prior art date
Application number
DK578585A
Other languages
Danish (da)
English (en)
Other versions
DK578585A (da
DK578585D0 (da
Inventor
Jr Raymond W Kosley
Robert J Cherill
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of DK578585D0 publication Critical patent/DK578585D0/da
Publication of DK578585A publication Critical patent/DK578585A/da
Application granted granted Critical
Publication of DK167218B1 publication Critical patent/DK167218B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK578585A 1984-12-14 1985-12-13 Aminoacyllabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af laegemidler DK167218B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68177984A 1984-12-14 1984-12-14
US68177984 1984-12-14

Publications (3)

Publication Number Publication Date
DK578585D0 DK578585D0 (da) 1985-12-13
DK578585A DK578585A (da) 1986-06-15
DK167218B1 true DK167218B1 (da) 1993-09-20

Family

ID=24736768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK578585A DK167218B1 (da) 1984-12-14 1985-12-13 Aminoacyllabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af laegemidler

Country Status (19)

Country Link
EP (1) EP0191166B1 (es)
JP (1) JPS61145178A (es)
KR (1) KR900007625B1 (es)
AR (1) AR243877A1 (es)
AT (1) ATE60767T1 (es)
AU (2) AU577912B2 (es)
CA (1) CA1307529C (es)
DE (1) DE3581725D1 (es)
DK (1) DK167218B1 (es)
ES (1) ES8703460A1 (es)
FI (1) FI87208C (es)
GR (1) GR852981B (es)
HU (1) HU201043B (es)
IE (1) IE58698B1 (es)
NO (1) NO171064C (es)
NZ (1) NZ214532A (es)
PH (1) PH24599A (es)
PT (1) PT81659B (es)
ZA (1) ZA859556B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
IN163242B (es) * 1985-05-03 1988-08-27 Hoechst India
JPS6310783A (ja) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd 新規フオルスコリン誘導体
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4734513A (en) * 1986-03-31 1988-03-29 Hoechst-Roussel Pharmaceuticals Inc. Method of synthesizing forskolin from 9-deoxyforskolin
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
NZ223051A (en) * 1986-12-29 1990-06-26 Hoechst Roussel Pharma Carbamoyloxylabdane derivatives and pharmaceutical compositions
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
US5051132A (en) * 1989-06-15 1991-09-24 Nippon Kayaku Kabushiki Kaisha Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
KR900007625B1 (ko) 1990-10-17
DE3581725D1 (de) 1991-03-14
PT81659B (pt) 1988-04-21
NZ214532A (en) 1989-05-29
PT81659A (en) 1986-01-01
FI854919A (fi) 1986-06-15
IE58698B1 (en) 1993-11-03
EP0191166A3 (en) 1988-03-02
ES549860A0 (es) 1987-02-16
FI87208B (fi) 1992-08-31
FI87208C (fi) 1992-12-10
EP0191166A2 (en) 1986-08-20
JPS61145178A (ja) 1986-07-02
ATE60767T1 (de) 1991-02-15
NO171064C (no) 1993-01-20
CA1307529C (en) 1992-09-15
ZA859556B (en) 1986-08-27
HUT40636A (en) 1987-01-28
NO171064B (no) 1992-10-12
AU3813289A (en) 1989-10-26
AU620421B2 (en) 1992-02-20
EP0191166B1 (en) 1991-02-06
AR243877A1 (es) 1993-09-30
ES8703460A1 (es) 1987-02-16
AU5131685A (en) 1986-07-17
NO855026L (no) 1986-06-16
HU201043B (en) 1990-09-28
IE853160L (en) 1986-06-14
PH24599A (en) 1990-08-17
FI854919A0 (fi) 1985-12-12
DK578585A (da) 1986-06-15
DK578585D0 (da) 1985-12-13
KR860004915A (ko) 1986-07-16
AU577912B2 (en) 1988-10-06
GR852981B (es) 1986-04-08

Similar Documents

Publication Publication Date Title
DK167218B1 (da) Aminoacyllabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af laegemidler
JP3045017B2 (ja) スチルベン誘導体及びそれを含有する制癌剤
US4639446A (en) Aminoacyllabdanes, pharmaceutical compositions and use
HUT75304A (en) Perhydroisoindole derivatives as p substance antagonists
CN103420942B (zh) 对乙、丁酰胆碱酯酶具有双重抑制活性化合物
WO2014146494A1 (zh) β-氨基羰基类化合物、其制备方法、药物组合物及其用途
HU203234B (en) Process for producing new, multiply oxygenated labdane derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IL93760A (en) History of N-3] 3-Ariyl) Hydroxyamino (methylphenyl [-3-) pyridyl (- H1, H3-pyrrolo] C-1,2 [thiazole-7-carboxamide, their preparation and pharmaceutical preparations containing them
HU211961A9 (en) 4-desoxy-4-epipodophyllotoxin derivatives and pharmaceutically acceptable salt thereof
US4673752A (en) Aminoacyllabdanes
US4666904A (en) Aminoacyllabdanes, pharmacuetical compositions and use
IE902750A1 (en) Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders
US4672115A (en) Process for preparing aminoacyllabdanes
EP0161867A2 (en) 5,6,7,8-Tetrahydroquinolines and 5,6-dihydropyrindines and their therapeutic use
JPS6110554A (ja) 置換−3−(2,3−ジヒドロ−1h−インデン−5−イル)−4−ヒドロキシ−1h−ピロ−ル−2,5−ジオン,その同族体及び塩
HU206875B (en) Process for producing carbamoyl-oxy-labdane derivatives and pharmaceutical compositions containing them as active components
JPH07503462A (ja) カルシウムチャンネル拮抗薬としてのアザビシクロ化合物
KR100564854B1 (ko) 제약 조성물
JPS62155253A (ja) グアニジノ安息香酸エステル誘導体
EP3763718A1 (en) Substituted 3,4,12,12a-tetrahydro-1h-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, pharmaceutical composition, and methods for preparing and using same
ES2402377T3 (es) Derivados del ácido fenilacético y composición farmacéutica de los mismos
JPH01242540A (ja) 新規カルコン誘導体および該誘導体を有効成分とする抗潰瘍剤
JPH07121915B2 (ja) 9−アミノテトラヒドロアクリジン類および関連化合物
EP0266246A1 (fr) Dérivés d'imidazo[4,5-b]pyridinone-2, leur préparation et leur application en thérapeutique
RU2036917C1 (ru) Производные кумарина или их фармацевтически приемлемая соль

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed